Chargement en cours...
Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?
PURPOSE: The docetaxel, 5-fluorouracil (5-FU), and cisplatin (TPF) regimen in India is associated with high percentages of Grade 3–4 toxicity. This analysis was planned to evaluate the incidence of dihydropyrimidine dehydrogenase (DPD) mutation in patients with severe gastrointestinal toxicity, to a...
Enregistré dans:
| Publié dans: | South Asian J Cancer |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5184753/ https://ncbi.nlm.nih.gov/pubmed/28032083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.195338 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|